Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C44H84NO8P |
| Molecular Weight | 786.1134 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 2 |
| E/Z Centers | 2 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC
InChI
InChIKey=SNKAWJBJQDLSFF-NVKMUCNASA-N
InChI=1S/C44H84NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h20-23,42H,6-19,24-41H2,1-5H3/b22-20-,23-21-/t42-/m1/s1
| Molecular Formula | C44H84NO8P |
| Molecular Weight | 786.1134 |
| Charge | 0 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 2 |
| E/Z Centers | 2 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Direct cerebrospinal fluid delivery of an antiretroviral agent using multivesicular liposomes. | 1990-09 |
|
| Evaluation of the thermal coefficient of the resistance to fluorophore rotation in model membranes. | 1989-06 |
|
| Effect of liposomes on lymphocytes: induction of proliferation of B lymphocytes and potentiation of the cytotoxic response of T lymphocytes to alloantigens. | 1986-06 |
|
| The ionic structure of lecithin monolayers. | 1967-05 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:11:49 GMT 2025
by
admin
on
Mon Mar 31 18:11:49 GMT 2025
|
| Record UNII |
H026DM5V6U
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
4235-95-4
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | |||
|
10350317
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | |||
|
52360
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | |||
|
DTXSID101274283
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | |||
|
H026DM5V6U
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | |||
|
224-193-8
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | |||
|
H026DM5V6U
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | |||
|
60428
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | |||
|
1424656
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY | RxNorm | ||
|
74669
Created by
admin on Mon Mar 31 18:11:49 GMT 2025 , Edited by admin on Mon Mar 31 18:11:49 GMT 2025
|
PRIMARY |